No trading action warranted. The CFO departure was pre-announced and the separation terms are standard. Monitor for appointment of a permanent CFO and next quarterly earnings for any strategic updates.
Price Chart
Executive Summary
Tango Therapeutics formalized the separation of former CFO Daniella Beckman, who was terminated without cause effective May 1, 2026. The separation agreement provides 12 months of base salary severance, COBRA premium reimbursement for up to 12 months, accelerated vesting of equity that would have vested over the next 24 months, and an extended stock option exercise period through August 31, 2026. This is a routine administrative filing formalizing a previously announced CFO departure with standard severance terms — no new material financial information or strategic implications.
Key Facts
- CFO Daniella Beckman's employment terminated without cause effective May 1, 2026; separation agreement signed May 7, 2026
- Severance includes 12 months of base salary paid in installments and COBRA premium reimbursement for up to 12 months
- Equity acceleration: unvested time-based options and RSUs that would have vested over 24 months post-termination will accelerate and vest as of termination date
- Stock option exercise period extended through August 31, 2026 for vested options
- CFO departure was previously announced on April 10, 2026, effective April 15, 2026
Financial Impact
Severance of 12 months base salary (amount not disclosed) plus COBRA premiums for up to 12 months and accelerated equity vesting — immaterial relative to $3.4B market cap
Risk Factors
- Prolonged CFO vacancy could create operational distraction
- No permanent CFO replacement named — succession timeline unclear
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-213491 |
| Document: d102174d8k.htm | 0001193125-26-213491 |
| Document: 0001193125-26-213491-index-headers.html | 0001193125-26-213491 |
| Document: 0001193125-26-213491-index.html | 0001193125-26-213491 |
| Document: 0001193125-26-213491.txt | 0001193125-26-213491 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | 8-K | $25.58 $25.20 | ▲ +1.49% | ▲ +1.04% | $23.20 (+9.28%) |
Aug 11, 2026 7w ago | 8-K | $26.34 $25.44 | ▼ −3.42% | ▼ −3.01% | $23.20 (−11.90%) |
Aug 11, 2026 7w ago | Press Release | $26.34 $25.44 | ▼ −3.42% | ▼ −3.01% | $23.20 (−11.90%) |
Aug 9, 2026 7w ago | Institutional Cluster | $27.67 $25.29 | ▼ −8.60% | ▼ −8.55% | $23.20 (−16.14%) |
Aug 6, 2026 8w ago | 8-K | $27.07 $25.60 | ▼ −5.43% | ▼ −5.83% | $23.20 (−14.28%) |
Jun 11, 2026 16w ago | 144 | $30.94 $27.97 | ▼ −9.60% | ▼ −10.27% | $23.20 (−25.00%) |
Jun 11, 2026 16w ago | Institutional Cluster | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 11, 2026 16w ago | Institutional Cluster | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 10, 2026 16w ago | 424B5 | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 10, 2026 16w ago | 144 | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access